Discover how a single high dose of psychedelic medicine impacts the neurological framework of individuals without pre-existing clinical conditions. This video breaks down a recent clinical trial evaluating psilocybin effects on healthy adults to understand its acute and long-term impact on the...
The psychedelic drug development landscape has reached an inflection point in early 2026, with Compass Pathways achieving the first positive Phase 3 psilocybin trial results in June 2025, while Lykos Therapeutics' MDMA rejection has reshaped industry expectations for regulatory rigor. Six...
Ibogaine is rapidly garnering attention as a potentially revolutionary treatment for addiction and related mental health disorders—a beacon of hope in landscapes often characterized by despair and systemic inadequacy. In a recent Fluence webinar, leading experts Dr. Bruno Rasmussen (Brazilian...
* Psychedelics are not panaceas, but they offer mechanisms of action distinct from conventional treatments. Substances such as MDMA, psilocybin, ibogaine, ketamine, and 5-MeO-DMT are demonstrating the capacity to disrupt entrenched neurobiological patterns associated with trauma, addiction, and...
Psychedelics have helped me and many others that I know through real dark times of addiction and depression.
My own breakthrough with psychedelics provided the breaking down of my belief systems and reawakened an overwhelmingly empowering sense of my own ability to change.
I’m super excited...
Abstract
Rates of alcohol use disorder (AUD) are increasing in men and women and there are high rates of concurrent posttraumatic stress disorder (PTSD) and AUD. AUD and PTSD synergistically increase symptomatology and negatively affect treatment outcomes; however, there are very limited...
In a study consisting of more than 180,000 male veterans aged 55 and older, those diagnosed with PTSD had nearly 2-fold the risk of developing dementia syndromes such as Alzheimer disease, frontotemporal dementia, Lewy Body dementia, vascular dementia, and senile dementia compared to those...
I am looking for anyone who has suffered from Mefloquine toxicity. This is an antimalarial drug that was handed out willy-nilly by several different nations' militaries.
I'm also looking for anyone who has filed for US VA disability for Mefloquine toxicity. I did talk with one guy who was...
On February 3, 2019, the Israeli Ministry of Health announced the approval of compassionate use for MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD), which will allow 50 patients to receive the therapy within a treatment protocol. Patients with PTSD will be eligible to...
"It seems that psychedelics do more than simply alter perception. According to the latest research from my colleagues and me, they change the structures of neurons themselves.
My research group has been studying the effects of psychedelics on neuronal structure and function, and we found that...
We see many threads here of members dealing with what may be symptoms of stress rather than side effects of their medication.
Stress that is symptomatic and on going is TSD, related to PTSD. Quality of life is diminished, interpersonal relations suffer. In our highly competitive fast paced...
I am hearing more buzz around research using psilocybin to treat PTSD and other mental health issues.
Has anyone tried microdosing? A friend with PTSD asked me and I just started reading about it. Here is a good guide:
THE ESSENTIAL GUIDE TO
MICRODOSING PSILOCYBIN MUSHROOMS
This thread is...
There are hundreds of thousands of people diagnosed with Post Traumatic Stress Disorder (PTSD) that are being treated with psychiatric medication and are not getting any better. They are dealing with insomnia, depression, anxiety, fatigue, decreased sex drive and substance abuse. Many of these...
MDMA, often known as Ecstasy or Molly, has for decades been used as a party drug — consumed in clubs, fuel for all-night raves. But lately, the substance is also being used in very different settings, for a very different purpose: to treat post-traumatic stress disorder.
The Food and Drug...